Table 5 Incidence of extremity or core arterial thromboemboli stratified by COVID-19 status and metabolic syndrome
From: Incidence and characteristics of arterial thromboemboli in patients with COVID-19
COVID-19 Test Negative N (%) | COVID-19 Test Positive N (%) | |
|---|---|---|
Extremity Thromboemboli | 5 | 9* |
With metabolic syndrome | 0 (0.00) | 4 (0.20) |
Without metabolic syndrome | 5 (0.05) | 5 (0.04) |
Core Thromboemboli | 33 | 14 |
With metabolic syndrome | 12 (0.57) | 7 (0.35) |
Without metabolic syndrome | 21 (0.19) | 7 (0.06) |